key: cord-0758784-hnb3ysek
authors: Kobayashi, Takaaki; Ortiz, Miguel E; Imborek, Katherine L; Alsuhaibani, Mohammed; Holley, Stephanie A; Trannel, Alexandra; Marra, Alexandre R; Etienne, William; Jenn, Kyle E; Abosi, Oluchi J; Meacham, Holly; Sheeler, Lorinda L; Dains, Angelique; Kukla, Mary E; McCray, Paul B; Perlman, Stanley; Ford, Bradley; Diekema, Daniel J; Wellington, Melanie; Salinas, Jorge L; Pezzulo, Alejandro A
title: Suspected COVID-19 Reinfections at a Tertiary Care Center, Iowa 2020
date: 2021-04-14
journal: Open Forum Infect Dis
DOI: 10.1093/ofid/ofab188
sha: 93ca10bf896aa97f0d4201f9474c094f8cd12e6d
doc_id: 758784
cord_uid: hnb3ysek

nan

M a n u s c r i p t 2 Text Dear Editor, Reinfections with Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) have been recently reported [1] [2] [3] [4] [5] . However, the rate of reinfections is difficult to determine because real-time reverse-transcription polymerase chain reaction (RT-PCR) can detect SARS-CoV-2 RNA for weeks after infection [6] , and criteria used to retest and define reinfections have varied.

Moreover, use of viral whole genome sequencing (WGS) to prove reinfection with new strains or clades [1] [2] [3] [4] [5] is not yet widely adopted. The Centers for Disease Control and Prevention (CDC) recently released a new COVID-19 reinfection investigation protocol with a time threshold ≥45 days from the first episode and a value for cycle threshold (Ct) <33 [7] . We used the CDC investigation protocol to determine the rate of clinically suspected reinfections at the University of Iowa Hospitals & Clinics (UIHC, an 811-bed Academic Medical Center) and confirmed one reinfection using whole genome sequencing.

Patients with respiratory complaints underwent SARS-CoV-2 RT-PCR using nasopharyngeal swabs. During March-April 2020, the CDC 2019-nCoVEUA-01 Diagnostic Panel (which uses two targets, N1 and N2 genes) was used; most subsequent samples were tested with the TaqPath RT-PCR COVID-19 Combo kit which uses three targets (ORF1ab, S gene, N gene).

We identified patients with laboratory-confirmed COVID-19 who underwent repeat RT-PCR ≥45 We summarized seven possible COVID-19 reinfections according to the CDC reinfection investigation criteria and confirmed one using WGS. One suspected reinfection in an immunosuppressed patient may have been a persistent infection [8] . Previously reported case series have not used a time threshold (≥45 days) or Ct values (<33) [9, 10] . Since a positive RT-PCR after recovery does not necessarily indicate reinfection, WGS can be used to further A c c e p t e d M a n u s c r i p t 4 confirm the diagnosis. In addition, given the emergence of new variants, there is a greater role of WGS, however, WGS is not yet routinely available for clinical use. Reinfections could be subclinical, and may not have been detected in our investigation; however, they could contribute to transmission. In conclusion, in patients with a recent history of COVID-19, recurrence of symptoms and a positive RT-PCR at least 45 days after the first diagnosis was rare (0.2%).

Among them, only one in four (0.05% of full cohort) had Ct values suggestive of reinfection/persistent infection, and none required hospitalization. M a n u s c r i p t 5 

A case of early reinfection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Coronavirus Disease 2019 (COVID-19) re-infection by a phylogenetically distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain confirmed by Whole Genome Sequencing

Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response

Reinfection risk of novel coronavirus (COVID-19): A systematic review of current evidence

Asymptomatic reinfection in 2 healthcare workers from India with genetically distinct Severe Acute Respiratory Syndrome Coronavirus 2

Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infectivity: when is it safe to discontinue isolation?

Investigative criteria for suspected cases of SARS-CoV-2 reinfection (ICR). Accessed

Persistence and evolution of SARS-CoV-2 in an immunocompromised host

Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?

Setting the criteria for SARS-CoV-2 reinfection -six possible cases

Research Ethic: This study was approved by the Institutional Review Board of the University of Iowa.

Informed consent for all subjects was waived according to the study design approved by the Institutional Review Board of the University of Iowa.

A c c e p t e d M a n u s c r i p t 6 A c c e p t e d M a n u s c r i p t 7